High-dose ursodeoxycholic acid in primary sclerosing cholangitis a randomised double-blind placebo-controlled trial

High-dose ursodeoxycholic acid in primary sclerosing cholangitis a randomised double-blind placebo-controlled trial

Bibliographic Details
Main Authors:	Bansi, D, Christie, J, Fleming, K, Chapman, R
Format:	Journal article
Published:	1996

Similar Items

High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomised double-blind, placebo-controlled trial.
by: Mitchell, S, et al.
Published: (1997)

High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomised double-blind, placebo-controlled trial.
by: Mitchell, SA, et al.
Published: (1997)

URSODEOXYCHOLIC ACID IN PRIMARY SCLEROSING CHOLANGITIS - A DOUBLE-BLIND PLACEBO CONTROLLED TRIAL
by: Lo, S, et al.
Published: (1992)

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis.
by: Mitchell, SA, et al.
Published: (2001)

High-dose ursodeoxycholic acid in the management of primary sclerosing cholangitis
by: Chapman, R
Published: (2005)

High-dose ursodeoxycholic acid in the management of primary sclerosing cholangitis
by: Chapman, R
Published: (2003)

High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective
by: Cullen, SN, et al.
Published: (2006)

Down regulation of interferon gamma and up regulation of interleukin-10 by ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC).
by: Mitchell, SA, et al.
Published: (1997)

High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective.
by: Cullen, SN, et al.
Published: (2008)

Medical treatment of primary sclerosing cholangitis with ursodeoxycholic acid.
by: Chapman, R
Published: (2003)

High-dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis: throwing the urso out with the bathwater?
by: Chapman, R
Published: (2009)

Primary sclerosing cholangitis: what is the role of ursodeoxycholic acid in therapy for PSC?
by: Chapman, R
Published: (2010)

norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
by: Fickert, P, et al.
Published: (2017)

A Prospective Trial of Withdrawal and Reinstitution of Ursodeoxycholic Acid in Pediatric Primary Sclerosing Cholangitis
by: Dennis D. Black, et al.
Published: (2019-11-01)

ABERRANT HLA-DR ANTIGEN EXPRESSION BY BILE-DUCT EPITHELIUM IN PRIMARY SCLEROSING CHOLANGITIS IS DOWN-REGULATED BY URSODEOXYCHOLIC ACID
by: Lo, S, et al.
Published: (1993)

IGG SUBCLASS DISTRIBUTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SCLEROSING CHOLANGITIS AND ULCERATIVE-COLITIS
by: Bansi, D, et al.
Published: (1995)

ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES AFTER LIVER-TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS
by: Bansi, D, et al.
Published: (1995)

Characterisation of the antigen for the antineutrophil cytoplasmic antibody specific for primary sclerosing cholangitis
by: Cameron, B, et al.
Published: (1998)

Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative colitis.
by: Bansi, D, et al.
Published: (1996)

ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES ARE ABSENT IN UNAFFECTED RELATIVES OF PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND ULCERATIVE-COLITIS
by: Bansi, D, et al.
Published: (1995)

Primary sclerosing cholangitis.
by: Chapman, R
Published: (1985)

Primary sclerosing cholangitis
by: Chapman, R
Published: (2007)

ANTINEUTROPHIL ANTIBODY AND PRIMARY SCLEROSING CHOLANGITIS
by: Lo, S, et al.
Published: (1991)

Primary sclerosing cholangitis.
by: Cullen, S, et al.
Published: (2003)

Serum miRNA profiles are altered in patients with primary sclerosing cholangitis receiving high-dose ursodeoxycholic acid
by: Jessica T. Hochberg, et al.
Published: (2023-06-01)

Primary sclerosing cholangitis.
by: Worthington, J, et al.
Published: (2006)

Primary sclerosing cholangitis.
by: Mitchell, SA, et al.
Published: (2000)

Primary sclerosing cholangitis.
by: Williamson, K, et al.
Published: (2014)

Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass.
by: Bansi, D, et al.
Published: (1996)

INTERFERON-GAMMA PRODUCTION IN PRIMARY SCLEROSING CHOLANGITIS
by: Martins, E, et al.
Published: (1995)

THE IMMUNOGENETICS OF PRIMARY SCLEROSING CHOLANGITIS
by: Chapman, R
Published: (1993)

Primary sclerosing cholangitis - Foreword
by: Chapman, R
Published: (2006)

The management of primary sclerosing cholangitis.
by: Chapman, R
Published: (2003)

The immunology of primary sclerosing cholangitis.
by: Chapman, R
Published: (1990)

A 2-year follow-up study of anti-neutrophil antibody in primary sclerosing cholangitis: relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatment.
by: Lo, S, et al.
Published: (1994)

Tissue distribution of autoantigen specific for primary sclerosing cholangitis.
by: Lo, S, et al.
Published: (1993)

Aetiopathogenesis of primary sclerosing cholangitis.
by: Cullen, S, et al.
Published: (2001)

Etiopathogenesis of primary sclerosing cholangitis.
by: Chapman, R, et al.
Published: (2008)

The management of primary sclerosing cholangitis.
by: Mitchell, SA, et al.
Published: (1998)

An update on primary sclerosing cholangitis.
by: Maggs, JR, et al.
Published: (2008)